IIR Globe IIR Data IIR
social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon

You are Trying to View a Premium Article

Drug Shortage Fears, Uncertainty Erupt in Puerto Rico Following Hurricane Maria

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 496 Words
Attachment: Puerto Rico Pharma Map

SUGAR LAND--September 29, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In the early morning of September 20, Puerto Rico took a direct hit from Hurricane Maria and its 150-mile-per-hour winds. The island is in shambles from the storm, as workers struggle to reestablish clean water, phone service and electric power. Governor Ricardo Rossello said that the situation was nearly a "humanitarian crisis." It is also a crisis of unknown ramifications for the island's most prominent industry, the Pharmaceutical-Biotech Industry.

Within this article: How the Pharmaceutical-Biotech Industry could be affected by Irma's ruinous path through Puerto Rico.

Companies featured: Abbott Laboratories (NYSE:ABT) (Abbott Park, Illinois), Amgen (NASDAQ:AMGN)(Thousand Oaks, California), Johnson & Johnson (NYSE:JNJ) (New Brunswick, New Jersey), Merck & Company Incorporated (NYSE:MRK) (Kenilwork, New Jersey) and Pfizer (NYSE:PFE) (New York, New York).


Login or Register for Instant Access

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type:

Pricing Help?

  • Pay-Per-Article - $5.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter